OSR2 and adenocarcinoma: Importantly, the knockdown of OSR2 in human adenocarcinoma (H838) cells significantly inhibited cell proliferation as compared to the non-targeting siRNA group (Figure 7D), suggesting a possible oncogenic role of OSR2 in lung cancer.